Correlation Between Caribou Biosciences and Marker Therapeutics
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Marker Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Marker Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Marker Therapeutics, you can compare the effects of market volatilities on Caribou Biosciences and Marker Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Marker Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Marker Therapeutics.
Diversification Opportunities for Caribou Biosciences and Marker Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Caribou and Marker is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Marker Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marker Therapeutics and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Marker Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marker Therapeutics has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Marker Therapeutics go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Marker Therapeutics
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Marker Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 1.38 times less risky than Marker Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Marker Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 277.00 in Marker Therapeutics on September 24, 2024 and sell it today you would earn a total of 103.00 from holding Marker Therapeutics or generate 37.18% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Marker Therapeutics
Performance |
Timeline |
Caribou Biosciences |
Marker Therapeutics |
Caribou Biosciences and Marker Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Marker Therapeutics
The main advantage of trading using opposite Caribou Biosciences and Marker Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Marker Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marker Therapeutics will offset losses from the drop in Marker Therapeutics' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Marker Therapeutics vs. Fate Therapeutics | Marker Therapeutics vs. Sana Biotechnology | Marker Therapeutics vs. Caribou Biosciences | Marker Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |